Invitation to the presentation of ALK's annual report 2025 on Friday, 20 February 2026

Group 1 - ALK will publish its annual report for 2025 on February 20, 2026, and will host a presentation for investors and analysts later that day at 1:30 p.m. CET [1] - The presentation will be led by ALK's management team, including Peter Halling (President & CEO), Claus Steensen Sølje (CFO), and Per Plotnikof (VP, Head of IR) [1] - The meeting will be available as a live audio webcast and can be replayed on ALK's website [2] Group 2 - Participants can join the conference call by registering through a provided link, and they will receive dial-in details via email [3] - The presentation materials will be accessible on ALK's website shortly before the meeting begins [4] Group 3 - ALK is a global specialty pharmaceutical company focused on allergy, involved in the entire value chain from development to marketing of products for respiratory allergies and anaphylaxis [6] - The company is headquartered in Denmark, employs around 2,700 people, and is listed on Nasdaq Copenhagen [6]